Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States

Shah, BD; Smith, NJ; Feng, CL; Jeyakumar, S; Castaigne, JG; Faghmous, I; Masouleh, BK; Malone, DC; Bishop, MR

Smith, NJ (通讯作者),Maple Hlth Grp LLC, 1740 Broadway,15th Floor, New York, NY 10019 USA.

ADVANCES IN THERAPY, 2022; 39 (8): 3678

Abstract

Introduction Despite currently available treatments for adults with relapsed/refractory acute lymphoblastic leukemia (R/R ALL), survival outcomes rema......

Full Text Link